Dupilumab Improves Dermatology-Specific Quality of Life in Patients with Chronic Spontaneous Urticaria Inadequately Controlled with H1 Antihistamines

Dupilumab
DOI: 10.1016/j.jaci.2023.11.033 Publication Date: 2024-02-05T09:31:51Z